Latest filing published 29 Apr 2026 for 명문제약.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 이경희 across 2 companies, led by 사이냅소프트 and 명문제약. Over a trading history stretching from 22 November 2024 to 28 April 2026, the count stands at 3 filings.
Both buying and selling appear: 2 purchases, against 1 sale. The totals do not cover 3 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2026: 1 purchase and 1 sale on the market.
Most recently, on 29 April 2026, the filings show an open-market purchase in 명문제약. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.